Cargando…
Boosting Abscopal Response to Radiotherapy with Sargramostim: A Review of Data and Ongoing Studies
Drug development in oncology today routinely focuses on approaches that utilize the patients’ immune system to destroy the malignancy. Combinatorial approaches of antineoplastic agents, both new and old, are being incorporated in the armamentarium of cancer treatments. The overarching goal of therap...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529041/ https://www.ncbi.nlm.nih.gov/pubmed/31157137 http://dx.doi.org/10.7759/cureus.4276 |